全体要約
嚢胞様黄斑浮腫（CME）は、中心網膜または黄斑に影響を与える無痛性の疾患で、網膜の腫れを引き起こす液体の嚢胞様の領域が特徴です。CMEは、血液網膜バリアの破壊によって引き起こされ、網膜内の細胞間スペースに液体が蓄積します。CMEには、原因が特定されている擬似水晶体手術後のものと、特定の臨床所見がない非擬似水晶体手術後のものの2種類があります。主な症状は、中心視力のぼやけや低下です。
2022年の世界の嚢胞様黄斑浮腫市場は、地域や市場セクターごとに分析され、2023年から2029年の予測が行われています。市場は、非ステロイド性抗炎症薬、抗血管内皮成長因子（VEGF）薬、炭酸脱水酵素阻害剤、ステロイドなどの製品タイプに分かれています。市場は、アメリカ、アジア太平洋、ヨーロッパ、中東・アフリカの地域に分かれ、各地域の主要企業がプロファイルされています。
関連する質問
EMMES, Fovea Pharmaceuticals, Icon Bioscience, Merck, Sanwa Kagaku Kenkyusho, Novartis, Johns Hopkins University, Wake Forest University, Iladevi Cataract, IOL Research Center, Rabin Medical Center, Kyushu University, Wills Eye Institute
血管内皮成長因子（VEGF）阻害剤の使用, 白内障手術後の合併症, 網膜手術に伴うリスク因子
概要
LPI (LP Information)の最新の調査報告書「嚢胞性黄斑浮腫産業予測」では、過去の売上を調査し、2022年の世界の嚢胞性黄斑浮腫の総売上をレビューしています。また、2023年から2029年までの地域および市場セクターごとの予測される嚢胞性黄斑浮腫の売上について包括的な分析を提供。地域、市場セクター、サブセクター別に分類された嚢胞性黄斑浮腫の売上により、この報告書は世界の嚢胞性黄斑浮腫産業の詳細な分析をUSドル百万単位で提供します。
このインサイトレポートは、世界の嚢胞性黄斑浮腫の状況について包括的な分析を提供し、製品セグメンテーション、企業形成、収益、マーケットシェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。また、本報告書は、嚢胞性黄斑浮腫のポートフォリオと能力、市場参入戦略、市場ポジション、地理的なフットプリントに焦点を当て、加速するグローバルな嚢胞性黄斑浮腫市場におけるこれら企業のユニークな位置をより良く理解するために、主要なグローバル企業の戦略も分析しています。
このインサイトレポートでは、シストイド黄斑浮腫の世界的な展望を形成する主要な市場動向、ドライバー、および影響因子を評価し、タイプ、アプリケーション、地域、市場規模別に予測を分解して、新たな機会の出現を強調しています。数百のボトムアップの定性的および定量的市場インプットに基づく透明な方法論を用いたこの研究予測は、シストイド黄斑浮腫の現在の状態と将来の軌道に関する非常に詳細な見解を提供します。
全球の嚢胞性黄斑浮腫市場の規模は、2022年のXX米ドルから2029年にはXX米ドルに成長することが予測されています。2023年から2029年にかけての年平均成長率（CAGR）はXX%成長すると期待されています。
CMEの原因は完全には知られていませんが、ぶどう膜炎、静脈閉塞、または糖尿病などのさまざまな疾患に伴う可能性があります。また、白内障手術後に一般的に発生することも知られています。嚢胞状黄斑浮腫に関連するさまざまな危険因子には、角膜移植（角膜移植手術）、網膜手術、慢性腎不全、網膜静脈閉塞、遺伝性網膜色素変性、全身投与の薬剤、および緑内障のための局所的なプロスタグランジンアナログがあります。この状態に対して特に人種や性別による好みは存在しません。ただし、嚢胞状黄斑浮腫は病因に基づいてあらゆる年齢で発生する可能性がありますが、高齢者はリスクが高くなります。
このレポートでは、製品タイプ、アプリケーション、主要プレーヤー、主要地域および国別の嚢胞性黄斑浮腫市場の包括的な概要、市場シェア、成長機会を示します。
市場セグメンテーション：
タイプ別セグメンテーション
非ステロイド性抗炎症薬
抗血管内皮増殖因子（VEGF）薬剤
炭酸脱水酵素阻害剤
ステロイド
アプリケーションによるセグメンテーション
病院
外来手術センター
その他
この報告書では、地域別に市場を分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下にプロファイルされている会社は、主要な専門家から収集した情報と、会社のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されました。
エメス
フォビアファーマシューティカルズ
アイコンバイオサイエンス
メルク
三和化学研究所
ノバルティス
ジョンズ・ホプキンズ大学
ウェイクフォレスト大学
イラデビ白内障
IOL研究センター
ラビン医療センター
九州大学
ウィルズアイ研究所
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの嚢胞様黄斑浮腫市場規模、（2018年～2029年）
2.1.2 嚢胞様黄斑浮腫市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 嚢胞様黄斑浮腫セグメント、タイプ別
2.2.1 非ステロイド性抗炎症薬
2.2.2 抗血管内皮増殖因子（VEGF）薬
2.2.3 カルボニックアンヒドラーゼ阻害剤
2.2.4 ステロイド
2.3 嚢胞様黄斑浮腫市場規模：タイプ別
2.3.1 嚢胞様黄斑浮腫市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの嚢胞様黄斑浮腫市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 嚢胞様黄斑浮腫セグメント、用途別
2.4.1 病院
2.4.2 外来手術センター
2.4.3 その他
2.5 嚢胞様黄斑浮腫市場規模：用途別
2.5.1 嚢胞様黄斑浮腫市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの嚢胞様黄斑浮腫市場規模、市場シェア（用途別）（2018年～2023年）
3 嚢胞様黄斑浮腫市場規模：プレイヤー別
3.1 嚢胞様黄斑浮腫市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける嚢胞様黄斑浮腫市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける嚢胞様黄斑浮腫市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの嚢胞様黄斑浮腫市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 嚢胞様黄斑浮腫、地域別
4.1 嚢胞様黄斑浮腫市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける嚢胞様黄斑浮腫市場規模成長（2018年〜2023年）
4.3 APACにおける嚢胞様黄斑浮腫市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける嚢胞様黄斑浮腫市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける嚢胞様黄斑浮腫市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける嚢胞様黄斑浮腫市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける嚢胞様黄斑浮腫市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける嚢胞様黄斑浮腫市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける嚢胞様黄斑浮腫市場規模、地域別（2018年〜2023年）
6.2 APACにおける嚢胞様黄斑浮腫市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける嚢胞様黄斑浮腫市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの嚢胞様黄斑浮腫 国別（2018年～2023年）
7.2 ヨーロッパにおける嚢胞様黄斑浮腫市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける嚢胞様黄斑浮腫市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの嚢胞様黄斑浮腫 地域別（2018年～2023年）
8.2 中東・アフリカにおける嚢胞様黄斑浮腫市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける嚢胞様黄斑浮腫市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの嚢胞様黄斑浮腫市場、市場予測
10.1 グローバルの嚢胞様黄斑浮腫、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの嚢胞様黄斑浮腫、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの嚢胞様黄斑浮腫、市場予測
10.1.3 APACの嚢胞様黄斑浮腫、市場予測
10.1.4 ヨーロッパの嚢胞様黄斑浮腫、市場予測
10.1.5 中東・アフリカの嚢胞様黄斑浮腫、市場予測
10.2 アメリカズの嚢胞様黄斑浮腫、市場予測（国別）（2024年～2029年）
10.3 APACの嚢胞様黄斑浮腫、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの嚢胞様黄斑浮腫、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの嚢胞様黄斑浮腫、市場予測（地域別）（2024年～2029年）
10.6 グローバルの嚢胞様黄斑浮腫、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの嚢胞様黄斑浮腫、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 EMMES
11.1.1 EMMES：企業情報
11.1.2 EMMES：嚢胞様黄斑浮腫分野の提供製品
11.1.3 EMMES：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 EMMES：主要事業概要
11.1.5 EMMES：直近の展開
11.2 Fovea Pharmaceuticals
11.2.1 Fovea Pharmaceuticals：企業情報
11.2.2 Fovea Pharmaceuticals：嚢胞様黄斑浮腫分野の提供製品
11.2.3 Fovea Pharmaceuticals：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.2.4 Fovea Pharmaceuticals：主要事業概要
11.2.5 Fovea Pharmaceuticals：直近の展開
11.3 Icon Bioscience
11.3.1 Icon Bioscience：企業情報
11.3.2 Icon Bioscience：嚢胞様黄斑浮腫分野の提供製品
11.3.3 Icon Bioscience：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Icon Bioscience：主要事業概要
11.3.5 Icon Bioscience：直近の展開
11.4 Merck
11.4.1 Merck：企業情報
11.4.2 Merck：嚢胞様黄斑浮腫分野の提供製品
11.4.3 Merck：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 Merck：主要事業概要
11.4.5 Merck：直近の展開
11.5 Sanwa Kagaku Kenkyusho
11.5.1 Sanwa Kagaku Kenkyusho：企業情報
11.5.2 Sanwa Kagaku Kenkyusho：嚢胞様黄斑浮腫分野の提供製品
11.5.3 Sanwa Kagaku Kenkyusho：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.5.4 Sanwa Kagaku Kenkyusho：主要事業概要
11.5.5 Sanwa Kagaku Kenkyusho：直近の展開
11.6 Novartis
11.6.1 Novartis：企業情報
11.6.2 Novartis：嚢胞様黄斑浮腫分野の提供製品
11.6.3 Novartis：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.6.4 Novartis：主要事業概要
11.6.5 Novartis：直近の展開
11.7 Johns Hopkins University
11.7.1 Johns Hopkins University：企業情報
11.7.2 Johns Hopkins University：嚢胞様黄斑浮腫分野の提供製品
11.7.3 Johns Hopkins University：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 Johns Hopkins University：主要事業概要
11.7.5 Johns Hopkins University：直近の展開
11.8 Wake Forest University
11.8.1 Wake Forest University：企業情報
11.8.2 Wake Forest University：嚢胞様黄斑浮腫分野の提供製品
11.8.3 Wake Forest University：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.8.4 Wake Forest University：主要事業概要
11.8.5 Wake Forest University：直近の展開
11.9 Iladevi Cataract
11.9.1 Iladevi Cataract：企業情報
11.9.2 Iladevi Cataract：嚢胞様黄斑浮腫分野の提供製品
11.9.3 Iladevi Cataract：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.9.4 Iladevi Cataract：主要事業概要
11.9.5 Iladevi Cataract：直近の展開
11.10 IOL Research Center
11.10.1 IOL Research Center：企業情報
11.10.2 IOL Research Center：嚢胞様黄斑浮腫分野の提供製品
11.10.3 IOL Research Center：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.10.4 IOL Research Center：主要事業概要
11.10.5 IOL Research Center：直近の展開
11.11 Rabin Medical Center
11.11.1 Rabin Medical Center：企業情報
11.11.2 Rabin Medical Center：嚢胞様黄斑浮腫分野の提供製品
11.11.3 Rabin Medical Center：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.11.4 Rabin Medical Center：主要事業概要
11.11.5 Rabin Medical Center：直近の展開
11.12 Kyushu University
11.12.1 Kyushu University：企業情報
11.12.2 Kyushu University：嚢胞様黄斑浮腫分野の提供製品
11.12.3 Kyushu University：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.12.4 Kyushu University：主要事業概要
11.12.5 Kyushu University：直近の展開
11.13 Wills Eye Institute
11.13.1 Wills Eye Institute：企業情報
11.13.2 Wills Eye Institute：嚢胞様黄斑浮腫分野の提供製品
11.13.3 Wills Eye Institute：嚢胞様黄斑浮腫収益・グロスマージンおよび市場シェア（2018年～2023年）
11.13.4 Wills Eye Institute：主要事業概要
11.13.5 Wills Eye Institute：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
LPI (LP Information)' newest research report, the “Cystoid Macular Edema Industry Forecast” looks at past sales and reviews total world Cystoid Macular Edema sales in 2022, providing a comprehensive analysis by region and market sector of projected Cystoid Macular Edema sales for 2023 through 2029. With Cystoid Macular Edema sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cystoid Macular Edema industry.
This Insight Report provides a comprehensive analysis of the global Cystoid Macular Edema landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cystoid Macular Edema portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cystoid Macular Edema market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cystoid Macular Edema and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cystoid Macular Edema.
The global Cystoid Macular Edema market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The cause of CME is not completely known though it may be accompanied by various diseases such as uveitis, vein occlusion or diabetes. It is also known to occur commonly after cataract surgery. Various risk factors associated with cystoids macular edema are penetrating keratoplasty (corneal transplant), retinal surgery, chronic renal failure, retinal vein occlusion, retinitis pigmentosa, systemic medication and topical prostaglandin analogs for glaucoma..No significant racial or sex related predilection exists for this condition. However, cystoids macular edema can occur at any age based on the etiology, though advanced age is at higher risk.
This report presents a comprehensive overview, market shares, and growth opportunities of Cystoid Macular Edema market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Non Steroidal Anti-Inflammatory Drugs
Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Carbonic Anhydrase Inhibitors
Steroids
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
EMMES
Fovea Pharmaceuticals
Icon Bioscience
Merck
Sanwa Kagaku Kenkyusho
Novartis
Johns Hopkins University
Wake Forest University
Iladevi Cataract
IOL Research Center
Rabin Medical Center
Kyushu University
Wills Eye Institute
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cystoid Macular Edema Market Size 2018-2029
2.1.2 Cystoid Macular Edema Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cystoid Macular Edema Segment by Type
2.2.1 Non Steroidal Anti-Inflammatory Drugs
2.2.2 Anti- Vascular Endothelial Growth Factor (VEGF) Agents
2.2.3 Carbonic Anhydrase Inhibitors
2.2.4 Steroids
2.3 Cystoid Macular Edema Market Size by Type
2.3.1 Cystoid Macular Edema Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cystoid Macular Edema Market Size Market Share by Type (2018-2023)
2.4 Cystoid Macular Edema Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Others
2.5 Cystoid Macular Edema Market Size by Application
2.5.1 Cystoid Macular Edema Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cystoid Macular Edema Market Size Market Share by Application (2018-2023)
3 Cystoid Macular Edema Market Size by Player
3.1 Cystoid Macular Edema Market Size Market Share by Players
3.1.1 Global Cystoid Macular Edema Revenue by Players (2018-2023)
3.1.2 Global Cystoid Macular Edema Revenue Market Share by Players (2018-2023)
3.2 Global Cystoid Macular Edema Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cystoid Macular Edema by Regions
4.1 Cystoid Macular Edema Market Size by Regions (2018-2023)
4.2 Americas Cystoid Macular Edema Market Size Growth (2018-2023)
4.3 APAC Cystoid Macular Edema Market Size Growth (2018-2023)
4.4 Europe Cystoid Macular Edema Market Size Growth (2018-2023)
4.5 Middle East & Africa Cystoid Macular Edema Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cystoid Macular Edema Market Size by Country (2018-2023)
5.2 Americas Cystoid Macular Edema Market Size by Type (2018-2023)
5.3 Americas Cystoid Macular Edema Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cystoid Macular Edema Market Size by Region (2018-2023)
6.2 APAC Cystoid Macular Edema Market Size by Type (2018-2023)
6.3 APAC Cystoid Macular Edema Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cystoid Macular Edema by Country (2018-2023)
7.2 Europe Cystoid Macular Edema Market Size by Type (2018-2023)
7.3 Europe Cystoid Macular Edema Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cystoid Macular Edema by Region (2018-2023)
8.2 Middle East & Africa Cystoid Macular Edema Market Size by Type (2018-2023)
8.3 Middle East & Africa Cystoid Macular Edema Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cystoid Macular Edema Market Forecast
10.1 Global Cystoid Macular Edema Forecast by Regions (2024-2029)
10.1.1 Global Cystoid Macular Edema Forecast by Regions (2024-2029)
10.1.2 Americas Cystoid Macular Edema Forecast
10.1.3 APAC Cystoid Macular Edema Forecast
10.1.4 Europe Cystoid Macular Edema Forecast
10.1.5 Middle East & Africa Cystoid Macular Edema Forecast
10.2 Americas Cystoid Macular Edema Forecast by Country (2024-2029)
10.2.1 United States Cystoid Macular Edema Market Forecast
10.2.2 Canada Cystoid Macular Edema Market Forecast
10.2.3 Mexico Cystoid Macular Edema Market Forecast
10.2.4 Brazil Cystoid Macular Edema Market Forecast
10.3 APAC Cystoid Macular Edema Forecast by Region (2024-2029)
10.3.1 China Cystoid Macular Edema Market Forecast
10.3.2 Japan Cystoid Macular Edema Market Forecast
10.3.3 Korea Cystoid Macular Edema Market Forecast
10.3.4 Southeast Asia Cystoid Macular Edema Market Forecast
10.3.5 India Cystoid Macular Edema Market Forecast
10.3.6 Australia Cystoid Macular Edema Market Forecast
10.4 Europe Cystoid Macular Edema Forecast by Country (2024-2029)
10.4.1 Germany Cystoid Macular Edema Market Forecast
10.4.2 France Cystoid Macular Edema Market Forecast
10.4.3 UK Cystoid Macular Edema Market Forecast
10.4.4 Italy Cystoid Macular Edema Market Forecast
10.4.5 Russia Cystoid Macular Edema Market Forecast
10.5 Middle East & Africa Cystoid Macular Edema Forecast by Region (2024-2029)
10.5.1 Egypt Cystoid Macular Edema Market Forecast
10.5.2 South Africa Cystoid Macular Edema Market Forecast
10.5.3 Israel Cystoid Macular Edema Market Forecast
10.5.4 Turkey Cystoid Macular Edema Market Forecast
10.5.5 GCC Countries Cystoid Macular Edema Market Forecast
10.6 Global Cystoid Macular Edema Forecast by Type (2024-2029)
10.7 Global Cystoid Macular Edema Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 EMMES
11.1.1 EMMES Company Information
11.1.2 EMMES Cystoid Macular Edema Product Offered
11.1.3 EMMES Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 EMMES Main Business Overview
11.1.5 EMMES Latest Developments
11.2 Fovea Pharmaceuticals
11.2.1 Fovea Pharmaceuticals Company Information
11.2.2 Fovea Pharmaceuticals Cystoid Macular Edema Product Offered
11.2.3 Fovea Pharmaceuticals Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Fovea Pharmaceuticals Main Business Overview
11.2.5 Fovea Pharmaceuticals Latest Developments
11.3 Icon Bioscience
11.3.1 Icon Bioscience Company Information
11.3.2 Icon Bioscience Cystoid Macular Edema Product Offered
11.3.3 Icon Bioscience Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Icon Bioscience Main Business Overview
11.3.5 Icon Bioscience Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Cystoid Macular Edema Product Offered
11.4.3 Merck Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Sanwa Kagaku Kenkyusho
11.5.1 Sanwa Kagaku Kenkyusho Company Information
11.5.2 Sanwa Kagaku Kenkyusho Cystoid Macular Edema Product Offered
11.5.3 Sanwa Kagaku Kenkyusho Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sanwa Kagaku Kenkyusho Main Business Overview
11.5.5 Sanwa Kagaku Kenkyusho Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Cystoid Macular Edema Product Offered
11.6.3 Novartis Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Johns Hopkins University
11.7.1 Johns Hopkins University Company Information
11.7.2 Johns Hopkins University Cystoid Macular Edema Product Offered
11.7.3 Johns Hopkins University Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Johns Hopkins University Main Business Overview
11.7.5 Johns Hopkins University Latest Developments
11.8 Wake Forest University
11.8.1 Wake Forest University Company Information
11.8.2 Wake Forest University Cystoid Macular Edema Product Offered
11.8.3 Wake Forest University Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Wake Forest University Main Business Overview
11.8.5 Wake Forest University Latest Developments
11.9 Iladevi Cataract
11.9.1 Iladevi Cataract Company Information
11.9.2 Iladevi Cataract Cystoid Macular Edema Product Offered
11.9.3 Iladevi Cataract Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Iladevi Cataract Main Business Overview
11.9.5 Iladevi Cataract Latest Developments
11.10 IOL Research Center
11.10.1 IOL Research Center Company Information
11.10.2 IOL Research Center Cystoid Macular Edema Product Offered
11.10.3 IOL Research Center Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 IOL Research Center Main Business Overview
11.10.5 IOL Research Center Latest Developments
11.11 Rabin Medical Center
11.11.1 Rabin Medical Center Company Information
11.11.2 Rabin Medical Center Cystoid Macular Edema Product Offered
11.11.3 Rabin Medical Center Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Rabin Medical Center Main Business Overview
11.11.5 Rabin Medical Center Latest Developments
11.12 Kyushu University
11.12.1 Kyushu University Company Information
11.12.2 Kyushu University Cystoid Macular Edema Product Offered
11.12.3 Kyushu University Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Kyushu University Main Business Overview
11.12.5 Kyushu University Latest Developments
11.13 Wills Eye Institute
11.13.1 Wills Eye Institute Company Information
11.13.2 Wills Eye Institute Cystoid Macular Edema Product Offered
11.13.3 Wills Eye Institute Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Wills Eye Institute Main Business Overview
11.13.5 Wills Eye Institute Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Cystoid Macular Edema Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Non Steroidal Anti-Inflammatory Drugs Table 3. Major Players of Anti- Vascular Endothelial Growth Factor (VEGF) Agents Table 4. Major Players of Carbonic Anhydrase Inhibitors Table 5. Major Players of Steroids Table 6. Cystoid Macular Edema Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 7. Global Cystoid Macular Edema Market Size by Type (2018-2023) & ($ Millions) Table 8. Global Cystoid Macular Edema Market Size Market Share by Type (2018-2023) Table 9. Cystoid Macular Edema Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 10. Global Cystoid Macular Edema Market Size by Application (2018-2023) & ($ Millions) Table 11. Global Cystoid Macular Edema Market Size Market Share by Application (2018-2023) Table 12. Global Cystoid Macular Edema Revenue by Players (2018-2023) & ($ Millions) Table 13. Global Cystoid Macular Edema Revenue Market Share by Player (2018-2023) Table 14. Cystoid Macular Edema Key Players Head office and Products Offered Table 15. Cystoid Macular Edema Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Cystoid Macular Edema Market Size by Regions 2018-2023 & ($ Millions) Table 19. Global Cystoid Macular Edema Market Size Market Share by Regions (2018-2023) Table 20. Global Cystoid Macular Edema Revenue by Country/Region (2018-2023) & ($ millions) Table 21. Global Cystoid Macular Edema Revenue Market Share by Country/Region (2018-2023) Table 22. Americas Cystoid Macular Edema Market Size by Country (2018-2023) & ($ Millions) Table 23. Americas Cystoid Macular Edema Market Size Market Share by Country (2018-2023) Table 24. Americas Cystoid Macular Edema Market Size by Type (2018-2023) & ($ Millions) Table 25. Americas Cystoid Macular Edema Market Size Market Share by Type (2018-2023) Table 26. Americas Cystoid Macular Edema Market Size by Application (2018-2023) & ($ Millions) Table 27. Americas Cystoid Macular Edema Market Size Market Share by Application (2018-2023) Table 28. APAC Cystoid Macular Edema Market Size by Region (2018-2023) & ($ Millions) Table 29. APAC Cystoid Macular Edema Market Size Market Share by Region (2018-2023) Table 30. APAC Cystoid Macular Edema Market Size by Type (2018-2023) & ($ Millions) Table 31. APAC Cystoid Macular Edema Market Size Market Share by Type (2018-2023) Table 32. APAC Cystoid Macular Edema Market Size by Application (2018-2023) & ($ Millions) Table 33. APAC Cystoid Macular Edema Market Size Market Share by Application (2018-2023) Table 34. Europe Cystoid Macular Edema Market Size by Country (2018-2023) & ($ Millions) Table 35. Europe Cystoid Macular Edema Market Size Market Share by Country (2018-2023) Table 36. Europe Cystoid Macular Edema Market Size by Type (2018-2023) & ($ Millions) Table 37. Europe Cystoid Macular Edema Market Size Market Share by Type (2018-2023) Table 38. Europe Cystoid Macular Edema Market Size by Application (2018-2023) & ($ Millions) Table 39. Europe Cystoid Macular Edema Market Size Market Share by Application (2018-2023) Table 40. Middle East & Africa Cystoid Macular Edema Market Size by Region (2018-2023) & ($ Millions) Table 41. Middle East & Africa Cystoid Macular Edema Market Size Market Share by Region (2018-2023) Table 42. Middle East & Africa Cystoid Macular Edema Market Size by Type (2018-2023) & ($ Millions) Table 43. Middle East & Africa Cystoid Macular Edema Market Size Market Share by Type (2018-2023) Table 44. Middle East & Africa Cystoid Macular Edema Market Size by Application (2018-2023) & ($ Millions) Table 45. Middle East & Africa Cystoid Macular Edema Market Size Market Share by Application (2018-2023) Table 46. Key Market Drivers & Growth Opportunities of Cystoid Macular Edema Table 47. Key Market Challenges & Risks of Cystoid Macular Edema Table 48. Key Industry Trends of Cystoid Macular Edema Table 49. Global Cystoid Macular Edema Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 50. Global Cystoid Macular Edema Market Size Market Share Forecast by Regions (2024-2029) Table 51. Global Cystoid Macular Edema Market Size Forecast by Type (2024-2029) & ($ Millions) Table 52. Global Cystoid Macular Edema Market Size Forecast by Application (2024-2029) & ($ Millions) Table 53. EMMES Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 54. EMMES Cystoid Macular Edema Product Offered Table 55. EMMES Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 56. EMMES Main Business Table 57. EMMES Latest Developments Table 58. Fovea Pharmaceuticals Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 59. Fovea Pharmaceuticals Cystoid Macular Edema Product Offered Table 60. Fovea Pharmaceuticals Main Business Table 61. Fovea Pharmaceuticals Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 62. Fovea Pharmaceuticals Latest Developments Table 63. Icon Bioscience Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 64. Icon Bioscience Cystoid Macular Edema Product Offered Table 65. Icon Bioscience Main Business Table 66. Icon Bioscience Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 67. Icon Bioscience Latest Developments Table 68. Merck Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 69. Merck Cystoid Macular Edema Product Offered Table 70. Merck Main Business Table 71. Merck Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 72. Merck Latest Developments Table 73. Sanwa Kagaku Kenkyusho Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 74. Sanwa Kagaku Kenkyusho Cystoid Macular Edema Product Offered Table 75. Sanwa Kagaku Kenkyusho Main Business Table 76. Sanwa Kagaku Kenkyusho Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 77. Sanwa Kagaku Kenkyusho Latest Developments Table 78. Novartis Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 79. Novartis Cystoid Macular Edema Product Offered Table 80. Novartis Main Business Table 81. Novartis Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 82. Novartis Latest Developments Table 83. Johns Hopkins University Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 84. Johns Hopkins University Cystoid Macular Edema Product Offered Table 85. Johns Hopkins University Main Business Table 86. Johns Hopkins University Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 87. Johns Hopkins University Latest Developments Table 88. Wake Forest University Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 89. Wake Forest University Cystoid Macular Edema Product Offered Table 90. Wake Forest University Main Business Table 91. Wake Forest University Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 92. Wake Forest University Latest Developments Table 93. Iladevi Cataract Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 94. Iladevi Cataract Cystoid Macular Edema Product Offered Table 95. Iladevi Cataract Main Business Table 96. Iladevi Cataract Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 97. Iladevi Cataract Latest Developments Table 98. IOL Research Center Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 99. IOL Research Center Cystoid Macular Edema Product Offered Table 100. IOL Research Center Main Business Table 101. IOL Research Center Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 102. IOL Research Center Latest Developments Table 103. Rabin Medical Center Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 104. Rabin Medical Center Cystoid Macular Edema Product Offered Table 105. Rabin Medical Center Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 106. Rabin Medical Center Main Business Table 107. Rabin Medical Center Latest Developments Table 108. Kyushu University Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 109. Kyushu University Cystoid Macular Edema Product Offered Table 110. Kyushu University Main Business Table 111. Kyushu University Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 112. Kyushu University Latest Developments Table 113. Wills Eye Institute Details, Company Type, Cystoid Macular Edema Area Served and Its Competitors Table 114. Wills Eye Institute Cystoid Macular Edema Product Offered Table 115. Wills Eye Institute Main Business Table 116. Wills Eye Institute Cystoid Macular Edema Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 117. Wills Eye Institute Latest Developments List of Figures Figure 1. Cystoid Macular Edema Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Cystoid Macular Edema Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Cystoid Macular Edema Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Cystoid Macular Edema Sales Market Share by Country/Region (2022) Figure 8. Cystoid Macular Edema Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Cystoid Macular Edema Market Size Market Share by Type in 2022 Figure 10. Cystoid Macular Edema in Hospitals Figure 11. Global Cystoid Macular Edema Market: Hospitals (2018-2023) & ($ Millions) Figure 12. Cystoid Macular Edema in Ambulatory Surgical Centers Figure 13. Global Cystoid Macular Edema Market: Ambulatory Surgical Centers (2018-2023) & ($ Millions) Figure 14. Cystoid Macular Edema in Others Figure 15. Global Cystoid Macular Edema Market: Others (2018-2023) & ($ Millions) Figure 16. Global Cystoid Macular Edema Market Size Market Share by Application in 2022 Figure 17. Global Cystoid Macular Edema Revenue Market Share by Player in 2022 Figure 18. Global Cystoid Macular Edema Market Size Market Share by Regions (2018-2023) Figure 19. Americas Cystoid Macular Edema Market Size 2018-2023 ($ Millions) Figure 20. APAC Cystoid Macular Edema Market Size 2018-2023 ($ Millions) Figure 21. Europe Cystoid Macular Edema Market Size 2018-2023 ($ Millions) Figure 22. Middle East & Africa Cystoid Macular Edema Market Size 2018-2023 ($ Millions) Figure 23. Americas Cystoid Macular Edema Value Market Share by Country in 2022 Figure 24. United States Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 25. Canada Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 26. Mexico Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 27. Brazil Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 28. APAC Cystoid Macular Edema Market Size Market Share by Region in 2022 Figure 29. APAC Cystoid Macular Edema Market Size Market Share by Type in 2022 Figure 30. APAC Cystoid Macular Edema Market Size Market Share by Application in 2022 Figure 31. China Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 32. Japan Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 33. Korea Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 34. Southeast Asia Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 35. India Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 36. Australia Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 37. Europe Cystoid Macular Edema Market Size Market Share by Country in 2022 Figure 38. Europe Cystoid Macular Edema Market Size Market Share by Type (2018-2023) Figure 39. Europe Cystoid Macular Edema Market Size Market Share by Application (2018-2023) Figure 40. Germany Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 41. France Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 42. UK Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 43. Italy Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 44. Russia Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 45. Middle East & Africa Cystoid Macular Edema Market Size Market Share by Region (2018-2023) Figure 46. Middle East & Africa Cystoid Macular Edema Market Size Market Share by Type (2018-2023) Figure 47. Middle East & Africa Cystoid Macular Edema Market Size Market Share by Application (2018-2023) Figure 48. Egypt Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 49. South Africa Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 50. Israel Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 51. Turkey Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 52. GCC Country Cystoid Macular Edema Market Size Growth 2018-2023 ($ Millions) Figure 53. Americas Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 54. APAC Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 55. Europe Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 56. Middle East & Africa Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 57. United States Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 58. Canada Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 59. Mexico Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 60. Brazil Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 61. China Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 62. Japan Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 63. Korea Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 64. Southeast Asia Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 65. India Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 66. Australia Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 67. Germany Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 68. France Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 69. UK Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 70. Italy Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 71. Russia Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 72. Spain Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 73. Egypt Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 74. South Africa Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 75. Israel Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 76. Turkey Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 77. GCC Countries Cystoid Macular Edema Market Size 2024-2029 ($ Millions) Figure 78. Global Cystoid Macular Edema Market Size Market Share Forecast by Type (2024-2029) Figure 79. Global Cystoid Macular Edema Market Size Market Share Forecast by Application (2024-2029)
